Reflux monitoring: pH-metry, Bilitec and Oesophageal impedance measurements

Best Practice and Research: Clinical Gastroenterology

Volumn 23, Issue 3, 2009, Pages 299-311

  Pohl, Daniel ^a   Tutuian, Radu ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

bilirubin monitoring; gastro oesophageal reflux disease; impedance pH monitoring; pH monitoring; proton pump inhibitors

Indexed keywords

ANTACID AGENT; BILIRUBIN; PROTON PUMP INHIBITOR;

ARTICLE; CLINICAL DECISION MAKING; CLINICAL FEATURE; ELECTRIC CONDUCTIVITY; ENDOSCOPY; ESOPHAGUS PH; FIBER OPTICS; FOOD REGURGITATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; IMPEDANCE; MULTICHANNEL RECORDER; OUTPATIENT CARE; PATIENT MONITORING; PREVALENCE; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; STOMACH CONTENT; THORAX PAIN;

BILIRUBIN; ELECTRIC IMPEDANCE; EQUIPMENT DESIGN; ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MONITORING, PHYSIOLOGIC; PROTON PUMP INHIBITORS;

EID: 66349123990     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2009.04.003     Document Type: Article

References (46)

1. Locke G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
2. Shaheen N.J., Hansen R.A., Morgan D.R., et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 101 (2006) 2128-2138
3. Allison P.R. Peptic ulcer of the esophagus. J Thorac Cardiovasc Surg 15 (1946) 308-317
4. Spencer J. Prolonged pH recording in the study of gastro-oesophageal reflux. Br J Surg 56 (1969) 912-914
5. Johnson L.F., and DeMeester T.R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62 (1974) 325-332
6. McLauchlan G., Rawlings J.M., Lucas M.L., et al. Electrodes for 24 hours pH monitoring - a comparative study. Gut 28 (1987) 935-939
7. Ward B.W., Wu W.C., Richter J.E., et al. Ambulatory 24-hour esophageal pH monitoring. Technology searching for a clinical application. J Clin Gastroenterol 8 Suppl. 1 (1986) 59-67
8. Dobhan R., and Castell D.O. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with '24-hr' analysis. Dig Dis Sci 37 (1992) 857-864
9. Gureneis P., and Orleanski A. On determination of the pH value of gastric juice by means of the internal radio sound, according to the H.G. Noeller (Heidelberg capsule). Wien Z Inn Med 45 (1964) 368-372
10. Pandolfino J.E., Richter J.E., Ours T., et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98 (2003) 740-749
11. Connell A.M., and Waters T.E. Assessment of gastric function by pH telemetring capsule. Lancet 189 (1964) 227-230
12. Scarpulla G., Camilleri S., Galante P., et al. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 102 (2007) 2642-2647
13. Piper D.W., and Fenton B.H. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 6 (1965) 506-508
14. Tuttle S.G., Rufin F., and Bettarello A. The physiology of heartburn. Ann Intern Med 55 (1961) 292-300
15. Stanciu C., Hoare R.C., and Bennett J.R. Correlation between manometric and pH tests for gastro-oesophageal reflux. Gut 18 (1977) 536-540
16. Vitale G.C., Sadek S., Tulley F.M., et al. Computerized 24-hour esophageal pH monitoring: a new ambulatory technique using radiotelemetry. J Lab Clin Med 105 (1985) 686-693
17. Weusten B.L., Roelofs J.M., Akkermans L.M., et al. Objective determination of pH thresholds in the analysis of 24 h ambulatory oesophageal pH monitoring. Eur J Clin Invest 26 (1996) 151-158
18. Agrawal A., Tutuian R., Hila A., et al. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci 50 (2005) 1916-1920
19. Johnsson F., Joelsson B., and Isberg P.E. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 28 (1987) 1145-1150
20. Schindlbeck N.E., Heinrich C., Konig A., et al. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 93 (1987) 85-90
21. Lam H.G., Breumelhof R., Roelofs J.M., et al. What is the optimal time window in symptom analysis of 24-h esophageal pressure and pH data?. Dig Dis Sci 39 (1994) 402-409
22. Breumelhof R., and Smout A.J. The symptom sensitivity index: a valuable additional parameter in 24-h esophageal pH recording. Am J Gastroenterol 86 (1991) 160-164
23. Weusten B.L., Roelofs J.M., Akkermans L.M., et al. The symptom-association probability: an improved method for symptom analysis of 24-h esophageal pH data. Gastroenterology 107 (1994) 1741-1745
24. Bredenoord A.J., Weusten B.L., and Smout A.J. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 54 (2005) 1810-1817
25. Barrett M.W., Myers J.C., Watson D.I., et al. Dietary interference with the use of Bilitec to assess bile reflux. Dis Esophagus 12 (1999) 60-64
26. Vaezi M.F., and Richter J.E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111 (1996) 1192-1199
27. Marshall R.E., Anggiansah A., Owen W.A., et al. The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 10 (1998) 385-392
28. Tack J., Koek G., Demedts I., et al. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?. Am J Gastroenterol 99 (2004) 981-988
29. Koek G.H., Sifrim D., Lerut T., et al. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52 (2003) 1397-1402
30. Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil 3 (1991) 151-162
31. Sifrim D., Castell D., Dent J., et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53 (2004) 1024-1031
32. Shay S.S., Tutuian R., Sifrim D., et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 99 (2004) 1037-1043
33. Zerbib F., des Varannes S.B., Roman S., et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 22 (2005) 1011-1021
34. Zentilin P., Iiritano E., Dulbecco P., et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis 38 (2006) 226-232
35. Srinivasan R., Vela M.F., Katz P.O., et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 280 (2001) G457-G462
36. Tutuian R., Mainie I., Agrawal A., et al. Normal values for ambulatory 24-h combined impedance-pH monitoring on acid suppressive therapy. Gastroenterology 130 Suppl. 2 (2006) A-171 [abstract]
37. Wildi S.M., Tutuian R., and Castell D.O. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol 99 (2004) 1645-1651
38. Vela M.F., Camacho-Lobato L., Srinivasan R., et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastro-esophageal reflux: effect of omeprazole. Gastroenterology 120 (2001) 1599-1606
39. Castell D.O., Kahrilas P.J., Richter J.E., et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 97 (2002) 575-583
40. Dean B.B., Gano Jr. A.D., Knight K., et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2 (2004) 656-664
41. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55 (2006) 1398-1402
42. Zerbib F., Roman S., Ropert A., et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 101 (2006) 1956-1963
43. Becker V., Bajbouj M., Waller K., et al. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther 26 (2007) 1355-1360
44. Wenner J., Johnsson F., Johansson J., and Oberg S. Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol 40 (2005) 768-774
45. Sweis R., Fox M., Anggiansah R., et al. Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther 29 (2009) 669-676
46. Lacy BE, Edwards S, Paquette L, et al. Tolerability and Clinical Utility of the Bravo pH Capsule in Children. J Clin Gastroenterol [Epub ahead of print].